Molecular epidemiology of rotavirus gastroenteritis in Central Kenya before vaccine introduction, 2009-2014

2016 ◽  
Vol 89 (5) ◽  
pp. 809-817 ◽  
Author(s):  
Ernest A. Wandera ◽  
Shah Mohammad ◽  
Satoshi Komoto ◽  
Yoshimasa Maeno ◽  
James Nyangao ◽  
...  
2018 ◽  
Vol 90 (6) ◽  
pp. 1040-1046 ◽  
Author(s):  
Nusrat Khandoker ◽  
Aksara Thongprachum ◽  
Sayaka Takanashi ◽  
Shoko Okitsu ◽  
Shuichi Nishimura ◽  
...  

2012 ◽  
Vol 33 (2) ◽  
pp. 64 ◽  
Author(s):  
Celeste Donato

Rotavirus is the principal aetiological agent of severe acute gastroenteritis in young children worldwide. Two vaccines, Rotarix [GlaxoSmithKline] and RotaTeq [Merck], have been developed to address the large burden of disease experienced worldwide. Both vaccines have been successful in decreasing morbidity and mortality associated with rotavirus gastroenteritis. Minor fluctuations in rotavirus epidemiology have been observed since vaccine introduction. However, it is unclear whether these observations are due to selection pressures specific to vaccine introduction or due to natural genotype fluctuations.


Author(s):  
Kiyoshi Kyo ◽  
Chika Takano ◽  
Yuki Kasuga ◽  
Erika Ogawa ◽  
Mika Ishige ◽  
...  

2008 ◽  
Vol 27 (1) ◽  
pp. 54-58 ◽  
Author(s):  
Michael J. Smith ◽  
H Fred Clark ◽  
Diane Lawley ◽  
Louis M. Bell ◽  
Richard L. Hodinka ◽  
...  

2017 ◽  
Vol 92 (3) ◽  
Author(s):  
Khuzwayo C. Jere ◽  
Chrispin Chaguza ◽  
Naor Bar-Zeev ◽  
Jenna Lowe ◽  
Chikondi Peno ◽  
...  

ABSTRACT To combat the high burden of rotavirus gastroenteritis, multiple African countries have introduced rotavirus vaccines into their childhood immunization programs. Malawi incorporated a G1P[8] rotavirus vaccine (Rotarix) into its immunization schedule in 2012. Utilizing a surveillance platform of hospitalized rotavirus gastroenteritis cases, we examined the phylodynamics of G1P[8] rotavirus strains that circulated in Malawi before (1998 to 2012) and after (2013 to 2014) vaccine introduction. Analysis of whole genomes obtained through next-generation sequencing revealed that all randomly selected prevaccine G1P[8] strains sequenced ( n = 32) possessed a Wa-like genetic constellation, whereas postvaccine G1P[8] strains ( n = 18) had a DS-1-like constellation. Phylodynamic analyses indicated that postvaccine G1P[8] strains emerged through reassortment events between human Wa- and DS-1-like rotaviruses that circulated in Malawi from the 1990s and hence were classified as atypical DS-1-like reassortants. The time to the most recent common ancestor for G1P[8] strains was from 1981 to 1994; their evolutionary rates ranged from 9.7 × 10 −4 to 4.1 × 10 −3 nucleotide substitutions/site/year. Three distinct G1P[8] lineages chronologically replaced each other between 1998 and 2014. Genetic drift was the likely driver for lineage turnover in 2005, whereas replacement in 2013 was due to reassortment. Amino acid substitution within the outer glycoprotein VP7 of G1P[8] strains had no impact on the structural conformation of the antigenic regions, suggesting that it is unlikely that they would affect recognition by vaccine-induced neutralizing antibodies. While the emergence of DS-1-like G1P[8] rotavirus reassortants in Malawi was therefore likely due to natural genotype variation, vaccine effectiveness against such strains needs careful evaluation. IMPORTANCE The error-prone RNA-dependent RNA polymerase and the segmented RNA genome predispose rotaviruses to genetic mutation and genome reassortment, respectively. These evolutionary mechanisms generate novel strains and have the potential to lead to the emergence of vaccine escape mutants. While multiple African countries have introduced a rotavirus vaccine, there are few data describing the evolution of rotaviruses that circulated before and after vaccine introduction. We report the emergence of atypical DS-1-like G1P[8] strains during the postvaccine era in Malawi. Three distinct G1P[8] lineages circulated chronologically from 1998 to 2014; mutation and reassortment drove lineage turnover in 2005 and 2013, respectively. Amino acid substitutions within the outer capsid VP7 glycoprotein did not affect the structural conformation of mapped antigenic sites, suggesting a limited effect on the recognition of G1-specific vaccine-derived antibodies. The genes that constitute the remaining genetic backbone may play important roles in immune evasion, and vaccine effectiveness against such atypical strains needs careful evaluation.


Vaccine ◽  
2018 ◽  
Vol 36 (47) ◽  
pp. 7131-7134 ◽  
Author(s):  
Christabel C. Enweronu-Laryea ◽  
George Armah ◽  
Kwamena W. Sagoe ◽  
Daniel Ansong ◽  
Emmanuel Addo-Yobo ◽  
...  

2016 ◽  
Vol 88 (9) ◽  
pp. 1511-1520 ◽  
Author(s):  
Aida Esteves ◽  
Johan Nordgren ◽  
Joana Pereira ◽  
Filomeno Fortes ◽  
Rafael Dimbu ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document